| Application no. and date | 97915441.6 (espacenet) (Federated) (European Patent Register), 19970326 | | Patent/reg. no. and date | DK/EP 0893996, 20020918 | | Publication date | 19990203 | | Priority no. and date | GB 9606452, 19960327 | | EP pub. no. and date |
EP 0893996 19990203 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 111835 | | Inventor | SCHULER, Walter, Rheinstrasse 21
D-79639 Grenzach-Wyhlen, DE,
SCHUURMAN, Hendrik, Breisacherstrasse 22
CH-4057 Basel, CH,
WECKBECKER, Gisbert, Loeliring 31
CH-4105 Biel-Benken, CH,
ZERWES, Hans-Günter, Holzgasse 55
D-79539 Lörrach, DE | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/435 (2006.01) , A61P 43/00 (2006.01) , A61P 9/00 (2006.01) | | Title | Anvendelse af et rapamycinderivat til behandling af karsygdomme og xenotransplantationer | | Int. application no. | EP1997001548 | | Int. publication no. | WO1997035575 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
